Comparison between the effect of carbamazepine and levetiracetam on children diagnosed with Rolandic epilepsy

Not Applicable

Recruiting

• Conditions: patient diagnosed with Rolandic syndrome.; Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset; G40.0

• Registration Number: IRCT20181014041338N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

children between age 6-12 years old (age of onset of disorder and eligible for the cognitive test)
diagnosed with Rolandic syndrome by using vEEG or EEG by a pediatric neurologist or epileptologist
having no previous history of using AEDs (Anti-epileptic drugs)
having no previous history of neurological and/or psychiatric and/or learning and/or genetical disorder(s) previous to the onset of Rolandic syndrome
having no history of using drugs that affect cognitive abilities significantly
signing ethical consent with total awareness and voluntary

Exclusion Criteria

patients who showed any side effects of Carbamazepine (like skin rash, Steven Johnson) and Levetiracetam (like suicide thoughts, acute behavioral problems due to Levetiracetam usage)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of preventing epilepsy attacks. Timepoint: before the drug usage and 2 weeks, 1 and 3 months after the drug usage. Method of measurement: recording the number of epilepsy attacks viewed by family.;Cognitive test score. Timepoint: before the intervention and 3 months after it. Method of measurement: using WISC 5 TEST.